PacBio (NASDAQ:PACB) saw its quarterly net loss widen to ~8% year over year as its Q1 2023 financial results missed on the bottom line
https://seekingalpha.com/news/3963993-pacbio-sees-quarterly-net-loss-widen-misses-on-bottom-line
PacBio (NASDAQ:PACB) saw its quarterly net loss widen to ~8% year over year as its Q1 2023 financial results missed on the bottom line
https://seekingalpha.com/news/3963993-pacbio-sees-quarterly-net-loss-widen-misses-on-bottom-line
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.